GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimer’s disease in 2033.

In December 2024, Western Europe’s PV selling rate continued its upward trend, reaching 13.1 million units/year. Year-on-year ...

The US Food and Drug Administration (FDA) has cleared Revvity’s automated chemiluminescence-based immunoassay (ChLIA) test ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

It’s become evident that a cloud-based IT portfolio brings organisations the greatest promise for providing the type of ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Overall EV sales gained 12%, pushing the full-year total to a record 1.3 million, according to forecasts from researcher Cox ...

Countries rearrange trade relationships according to geopolitical alliances as the world awaits a rise in US protectionism.

Automotive production and inventory, and ultimately sales, all took a massive hit and still have not been the same since, reports GlobalData.

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...